Product
Homepage
/
Products and Services
/
Active pharmaceutical ingredients
/
Intermediate
/
钆布醇中间体60239-18-1

Popular information

Viwit participates in CPhI China 2019, booth: W2B28 2019-06-18 01:34:00
CPhI China 2019 will be held at Shanghai New International Expo Center on June 18-20, 2019. Welcome to patronage of Viwit, booth number: W2B28. If you would like to make an appointment in advance, please email us at service@viwit.com.
CPhI India 2018, Booth No. 4.H15 2018-12-12 01:34:00
CPhI India 2018, Booth No. 4.H15 CPhI India 2018 will take place on Dec. 12 - Dec. 14, 2018 at India Expo Center, India. Please visit us on CPhI India 2018, Booth No. 4.H15. If you would like to make an appointment, please send an e-mail to service@viwit.com.
Wellcome participates in CPhI India 2018, booth number: 4.H15 2018-12-12 01:32:00
Wellcome participates in CPhI India 2018, booth number: 4.H15 CPhI India 2018 will be held from December 12th to 14th, 2018 at the Expo Center in Delhi, India. Welcome to patronage of Viwit, booth number: 4.H15. If you want to make an appointment in advance, please send an email to service@viwit.com
Congratulations to Shandong Viwit Pharmaceutical Industry Co., Ltd. for passing GMP certification of Health Canada 2018-10-11 01:32:00
In September 2018, Viwit's API factory in Tengzhou, Shandong Province ushered in a five-day GMP audit by Health Canada. In the end, Wellcome successfully completed the GMP inspection by Health Canada and achieved excellent results. Any regulatory inspection is a challenge, but it is also a great opportunity to demonstrate your capabilities. Viwit has always adhered to the concept of cGMP standards and is committed to following high standards of quality management system. The successful on-site inspection by Health Canada is another milestone achieved by Viwit as a world-leading pharmaceutical and health company. Viwit will continue to follow the cGMP standard for each operation procedure to provide the market with safer and higher quality products.
Wellcome participates in CPhI Worldwide 2018, booth number: 7A80 2018-10-09 01:33:00
CPhI Worldwide 2018 will be held on October 9-11, 2018 at the Madrid International Convention and Exhibition Center in Spain. Welcome to patronage of Viwit, booth number: 7A80. If you want to make an appointment in advance, please send an email to service@viwit.com
Wellcome participated in CPhI China 2018, booth: W2A09 2018-06-20 01:33:00
CPhI China 2018 will be held at Shanghai New International Expo Center from June 20th to 22nd, 2018. Welcome to patronize Viwit, booth number: W2A09. If you would like to make an appointment in advance, please email us at service@viwit.com.

钆布醇中间体60239-18-1

【别名】DOTA
【目录号】HC6601
【CAS #】 60239-18-1
【分子式】C16H28N4O8
【产品简介】1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸，英文名为DOTA，美国化学文摘登记号为cas 60239-18-1。
English Name :
CAS# :
q
产品描述
[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[产品参数, 参数]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]

※1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸

DOTA
CAS 60239-18-1

 

别 名

DOTA

目录号

HC6601

CAS #

60239-18-1

分子式

C16H28N4O8

分子量

404.42

结构式

威智医药

产品简介

CAS 60239-18-1

1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸，英文名为DOTA，美国化学文摘登记号为cas 60239-18-1。

钆布醇是（cas 60239-18-1）含钆的造影剂。此种药物是供患者中枢神经系统的磁共振成像（MRI）检查使用。并且，钆布醇于2011年3月通过了美国食品药品管理局（FDA）批准。
 

 

扫二维码用手机看
未找到相应参数组，请于后台属性模板中添加
上一个
Eletriptan intermediate
下一个
Cyclen 294-90-6
search
Confirm
Close
About Us
Company Introduction Corporate History Business Introduction Corporate Governance Company Culture Corporate Honors Viwit Home
R&D and Innovation
R&D Innovation Product Pipeline Achievements
Products
Drug Products Biologics APIs Intermediates Boranes
Innovation
CDMO Project Collaboration In-/Out-Licensing Joint Venture
Sustainable
EHS Energy Quality Supplier
News Center
In 2020 In 2019 In 2018 In 2017 In 2016
Join Us
Talent Philosophy Talent Development Salary and Benefits Campus Recruiting Social Recruitment
Contact Us
Online Message Contact Us
dp EN
dp 中文

wz

wz